Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
More recently, two dual-acting GLP-1/GIP agonists have been approved, Mounjaro (tirzepatide) for type 2 diabetes and Zepbound (tirzepatide) for chronic weight management
Skipping titration increases the likelihood of severe nausea, vomiting, prolonged diarrhea , and potentially dangerous dehydration
Clinical research and our experience show that long-term use (over 16 months) can lead to an average weight loss of up to 15% of starting body weight
After patients reach a healthy and stable weight, they stay on the highest dose they are tolerating in order to maintain their current weight
Family Medical clinic offers treatments for pediatrics including immunizations, wellness exams, diabetic care, and more
"It should be used only for short periods to quell acute nausea, not chronically to permit rapid dose escalation
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
